Company Logo

Myrcludex B

Pharmaceutical Information

Updated on Jun 11, 2019

View more like this | Visit SHIRLEY, NY | Contact Cathy Miller
Image for Myrcludex B with ID of: 3526273
Myrcludex B is an experimental drug for the treatment of hepatitis B and D. The hepatitis B virus uses its surface lipopeptide pre-S1 for docking to mature liver cells via their sodium/bile acid cotransporter (NTCP) and subsequently entering the cells. Myrcludex B is a synthetic N-acylated pre-S1 that can also dock to NTCP, blocking the virus's entry mechanism.
goodideazs, LLC is not affiliated with the authors of this post nor is it responsible for its content, the accuracy and authenticity of which should be independently verified.